Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
Doctors and immunologists implement a new approach for melanoma treatment
Worldwide, the incidence rate of skin cancer, like other types of cancer, is increasing. People…
Patients suffer invasive treatments for harmless cancers
Australians are increasingly being diagnosed with cancers that will do them no harm if left…
Shortness of breath and cough increase as first symptom of lung cancer
GPs are being urged to consider shortness of breath and cough as potential predictors of…
Black breast cancer patients have worse outcomes than whites, despite similar treatments
- SABCS 2018: Low-dose tamoxifen was safe and effective at reducing recurrence and new breast disease for patients with DCIS, LCIS, and ADH
- SABCS 2018: Circulating tumour cell count could help choose treatment for metastatic breast cancer patients
- SABCS 2018: Axillary radiotherapy and lymph node surgery yielded comparable 10-year outcomes for patients with breast cancer
Nutraceuticals are often big on promise but fail to deliver
By Nial Wheate – University of Sydney. Extracts from a berry can improve the effectiveness of a chemotherapy drug, according to research published…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.